相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein
Justin McCue et al.
BIOLOGICALS (2015)
Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity
Eloise Perot et al.
THROMBOSIS RESEARCH (2015)
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
Frank Behrens et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality
William C. Yang et al.
BIOTECHNOLOGY PROGRESS (2014)
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
Johnny Mahlangu et al.
BLOOD (2014)
The choice of mammalian cell host and possibilities for glycosylation engineering
Michael Butler et al.
CURRENT OPINION IN BIOTECHNOLOGY (2014)
Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
Carol Wysham et al.
DIABETES CARE (2014)
Validation of the manufacturing process used to produce long-acting recombinant factor IX Fc fusion protein
J. McCue et al.
HAEMOPHILIA (2014)
Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept-Targeted Drug Delivery with Antibody-Drug Conjugates for Cancers
Rodney J. Y. Ho et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Addition of Valproic Acid to CHO Cell Fed-Batch Cultures Improves Monoclonal Antibody Titers
William C. Yang et al.
MOLECULAR BIOTECHNOLOGY (2014)
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Kathleen M. Dungan et al.
LANCET (2014)
A simple, robust and highly efficient transient expression system for producing antibodies
Tom Vink et al.
METHODS (2014)
Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase
Ari Zimran et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease
Hadhami Ben Turkia et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems
Yoram Tekoah et al.
BIOSCIENCE REPORTS (2013)
Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
R. T. Peters et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
Jerry S. Powell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Production of Recombinant Therapeutic Proteins in Human Cells: Current Achievements and Future Perspectives
Virginia Picanco-Castro et al.
PROTEIN AND PEPTIDE LETTERS (2013)
Use of baculovirus expression system for generation of virus-like particles: Successes and challenges
Fuxiao Liu et al.
PROTEIN EXPRESSION AND PURIFICATION (2013)
Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII
Christoph Kannicht et al.
THROMBOSIS RESEARCH (2013)
Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production
Tingfeng Lai et al.
PHARMACEUTICALS (2013)
CHO cells in biotechnology for production of recombinant proteins: current state and further potential
Jee Yon Kim et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2012)
Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation
Darius Ghaderi et al.
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS VOL 28, ISSUE 1 (2012)
Analysis of dynamic changes in the proteome of a Bcl-XL overexpressing Chinese hamster ovary cell culture during exponential and stationary phases
Tyler Carlage et al.
BIOTECHNOLOGY PROGRESS (2012)
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
Amy D. Shapiro et al.
BLOOD (2012)
Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
Jennifer A. Dumont et al.
BLOOD (2012)
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
Jerry S. Powell et al.
BLOOD (2012)
Sepsis update: management of severe sepsis and septic shock in the emergency department after the withdrawal of Xigris
Robert S. Green et al.
CANADIAN JOURNAL OF EMERGENCY MEDICINE (2012)
The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
Elisabeth Casademunt et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Effect of hypothermic temperatures on production of rabies virus glycoprotein by recombinant Drosophila melanogaster S2 cells cultured in suspension
Nickeli Rossi et al.
JOURNAL OF BIOTECHNOLOGY (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Multi-Omics Analysis of Recombinant Protein Production in Hek293 Cells
Stefanie Dietmair et al.
PLOS ONE (2012)
Human cells: New platform for recombinant therapeutic protein production
Kamilla Swiech et al.
PROTEIN EXPRESSION AND PURIFICATION (2012)
Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications
Nathalie Enjolras et al.
THROMBOSIS RESEARCH (2012)
Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII
Kamilla Swiech et al.
BMC BIOTECHNOLOGY (2011)
Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice
Massimo Franchini et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Erythropoietin Produced in a Human Cell Line (Dynepo) Has Significant Differences in Glycosylation Compared with Erythropoietins Produced in CHO Cell Lines
Zahra Shahrokh et al.
MOLECULAR PHARMACEUTICS (2011)
The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xun Xu et al.
NATURE BIOTECHNOLOGY (2011)
Virus Susceptibility of Chinese Hamster Ovary (CHO) Cells and Detection of Viral Contaminations by Adventitious Agent Testing
Andreas Berting et al.
BIOTECHNOLOGY AND BIOENGINEERING (2010)
Prolonged activity of factor IX as a monomeric Fc fusion protein
Robert T. Peters et al.
BLOOD (2010)
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
Wolfgang Glaesner et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
An improved manufacturing process for Xyntha/ReFacto AF
B. Kelley et al.
HAEMOPHILIA (2010)
Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins
Carlos J. Bosques et al.
NATURE BIOTECHNOLOGY (2010)
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
Darius Ghaderi et al.
NATURE BIOTECHNOLOGY (2010)
Expression systems for therapeutic glycoprotein production
Yves Durocher et al.
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety
Michael Beck
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II
J. Edmond Wraith
ACTA PAEDIATRICA (2008)
Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)
Esther Llop et al.
ANALYTICAL BIOCHEMISTRY (2008)
An overview of animal cell substrates for biological products
John Petricciani et al.
BIOLOGICALS (2008)
Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity
M. J. E. Havenga et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells
Martin Loignon et al.
BMC BIOTECHNOLOGY (2008)
Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection
Gudrun Schiedner et al.
BMC BIOTECHNOLOGY (2008)
Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
Vered Padler-Karavani et al.
GLYCOBIOLOGY (2008)
Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose
Christine H. Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
A. B. H. Bakker et al.
VACCINE (2008)
Effect of Differential N-linked and O-linked Mannosylation on Recognition of Fungal Antigens by Dendritic Cells
Jennifer S. Lam et al.
PLOS ONE (2007)
Glycosylation engineering in yeast: the advent of fully humanized yeast
Stephen R. Hamilton et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Treatment of Fabry Disease: Outcome of a Comparative Trial with Agalsidase Alfa or Beta at a Dose of 0.2 mg/kg
Anouk C. Vedder et al.
PLOS ONE (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins
James N. Arnold et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Expression of human coagulation factor VIII in a human hybrid cell line, HKB11
Baisong Mei et al.
MOLECULAR BIOTECHNOLOGY (2006)
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants
ABH Bakker et al.
JOURNAL OF VIROLOGY (2005)
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
TA Kost et al.
NATURE BIOTECHNOLOGY (2005)
Production of recombinant protein therapeutics in cultivated mammalian cells
FM Wurm
NATURE BIOTECHNOLOGY (2004)
Advances in the production of human therapeutic proteins in yeasts and filamentous fungi
TU Gerngross
NATURE BIOTECHNOLOGY (2004)
Production of complex human glycoproteins in yeast
SR Hamilton et al.
SCIENCE (2003)
A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease
K Lee et al.
GLYCOBIOLOGY (2003)
High-level expression of recombinant IgG in the human cell line PER.C6
D Jones et al.
BIOTECHNOLOGY PROGRESS (2003)
Versatile expression system for rapid and stable production of recombinant proteins
MS Cho et al.
BIOTECHNOLOGY PROGRESS (2003)
Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo
K Yamaguchi et al.
MOLECULAR THERAPY (2003)
Expression and characterization of recombinant human antithrombin III in Pichia pastoris
S Mochizuki et al.
PROTEIN EXPRESSION AND PURIFICATION (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
